J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e82
Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma:First Report in Korean Population
Lim1, H; Son, MH; Hyun, JK; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Sung, KW; Koo, HH

PEDIATR BLOOD CANCER 2020 10.1002/pbc.28066
Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation
Yi1, ES; Son, MH; Hyun, JK; Cho, HW; Ju, HY; Lee, JW; Yoo, KH; Sung, KW; Koo, HH

J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e254
Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
Seo1, E; Kim, JS; Ma, YE; Cho, HW; Ju, HY; Lee, SH; Lee, JW; Yoo, KH; Sung, KW; Koo, HH

J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e260
Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
Cho1, HW; Lee, JW; Ma, Y; Yoo, KH; Sung, KW; Koo, HH

PEDIATR BLOOD CANCER 2018 10.1002/pbc.27257
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
Lee1, JW; Son, MH; Cho, HW; Ma, YE; Yoo, KH; Sung, KW; Koo, HH